MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. IBM
6. PRIM
7. SPY
8. ACN
9. NVDA
10. BLZE

Go back to MetaVia reports obesity drug achieves 9.1% weight loss in phase 1 study
(NASDAQ: MTVA) Delayed: 1.55 -0.02 (1.27%)
Previous Close $1.57    52 Week High $ 
Open $1.52    52 Week Low $ 
Day High $1.64    P/E N/A 
Day Low $1.50    EPS $ 
Volume 494,052